Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Thanks everyone for your inputs, deeply appreciated. There are enough money in 529 to support both kids through college. Her house was paid in full when my friend realized that he didn't have enough time left. I recently suggested her to talk to adv…
I personally prefer managers to spend their working hours to focus on portfolio, answering a potential investor's call should be handled by other supporting personal on the team.
Three of my biotech holdings (pcyc, geva and rcpt) have been aquired so far this year, valuation is high in the biotech sect. Glad bought two Chinese ADR QUNR and CTRP last week. CELG is very good at BD activity, personally think they got RCPT at g…
The stocks loncar picked for the index are general good but highly risky, there are a few which I would not touch it, I would be careful. If you like this immunooncology space, you can play it with big boys in the space such as BMY/ mrk/ AZN, small …
Thanks Scott, I am also very much interested in rail stocks.
Regarding NASH, if you like this indication and have a long term view, please check out ICPT, the company just announced that they have an agreement with FDA on their phase III design on …
I own both GILD and BMY, but prefer to add to BMY to GILD, BMS has several break through immuno oncology assets which could transform the cancer treatment particularly in melanoma and lung cancer, the concern with GILD is that what is after HCV, tho…
@old skeet, lpefx is interesting fund, it's holdings are mostly public traded private equity managing companies who profit from the assets they are managing, the money you invested in this fund don't directly investe in the private buyouts, am I rig…
@msf, I was in China two month ago, visited several third tier small cities, all hotels and department stores I stayed and shopped accept Visa Or MC card. For the small charges In mom and pap shops I used local currency, have no trouble to use BAC v…
I can use both Visa and MC in pretty much everywhere I went even in the third tier cities, believe it or not their bank system is quite advanced and ATMs are everywhere, I normally used my BAC card to get the local currency without any issue.
Can not argue with you and lived through the dot.com period. I still invest in tech and bio lands with moderate allocation, but this manager has done well in the short term.
I filed my tax using TT in the past few years without any problems with K1, the major issue i have this year is that my accountant don't feel comfortable to file the return with estimated K1 from Oaktree and want me to file the disclosure form.
The one you can downloaded from their web is estimate; my Tax guy told me that I need to file a Disclosure Statement form 8275 if using this K1 estimate. I received all other final K1s except this one.
Position size is important; personally I start with $50k then slowly add to it if the fundamental remains excellent, hold them for a long time (more than 5 years). If you pick the right ones such as PANW or PCYC and even a few bad choices, you still…
Added to ASHR, Chinese A share is on fire in the last few months and glad having started the position in the middle of last year. XNCR is one of the small cap biotechs I like.
Love the periodic table and very creative.
Agree with Scott that wine/liquor stocks are usually good long term holding, I own both STZ and DEO, very happy with STZ thus far.
Please keep in mind that both pharmaceutical and biotech stocks were flat for almost a decade and started to move in the right direction only three years ago.
The managers of ETAGX is experienced in picking the biotech winners such as AGIO and MDVN this year, many of their health care holdings are in the biotech space, they know the space for sure, their resume is impressive too.
Kris Jenner started his hedge fund Rocks Spring capital last October, so far his fund is doing better than TR health care fund and most other health care related funds.
